Skip to main content
. 2013 Oct 7;7:32. doi: 10.3389/fnana.2013.00032

Table 1.

Primary and secondary antibodies used in the study.

Labeling agent Dilutions and specifications
PRIMARY
Polyclonal rabbit anti-FMRFamide 1:2000; Acris/Immunostar; Cat. No. 20091; Harzsch et al., 2011; Krieger et al., 2012; Kenning et al., 2013
Monoclonal mouse anti-synapsin 1:30; SYNORF1, DSHB; Harzsch et al., 2011; Krieger et al., 2012; Kenning et al., 2013
Polyclonal rabbit anti-5-HT 1:1000; Immunostar, Cat. No. 20080, Kenning et al., 2013
Anti-tyronisated tubulin 1:1000; Sigma–Aldrich; Cat. No.T9028; Sombke et al., 2011; Kenning et al., 2013
SECONDARY
Anti-rabbit AlexaFluor488 Goat anti-rabbit IgG (H + L) antibody, Invitrogen; MolecularProbes; Cat. No. A-11008
Anti-mouse Cy3 Cy3-conjugated AffiniPure goat anti-Mouse IgG (H + L) antibody, Jackson ImmunoResearch Laboratories Inc. Cat. No. 115-165-003
NUCLEAR COUNTER STAIN
0.05%, bisBenzimid H 33258, Sigma–Aldrich; Cat. No. 23491-45-4